Report Detail
Global GP681 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4702017 |
- 01 June, 2026 |
- Global |
- 81 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global GP681 market size was valued at US$ 36.01 million in 2025 and is forecast to a readjusted size of US$ 195 million by 2032 with a CAGR of 7.9% during review period.
GP681 is a novel oral antiviral drug targeting influenza viruses, belonging to the class of cap‑dependent endonuclease inhibitors. It blocks the function of the polymerase acidic protein of influenza viruses, thereby inhibiting viral nucleic acid replication and transcription and rapidly controlling the infection process.
The drug features single‑dose administration, rapid onset of action, and low incidence of drug resistance. It exhibits potent inhibitory activity against both influenza A and B viruses, and is clinically indicated for the treatment of influenza A and B in people aged 12 years and older.
With high safety and convenient administration, GP681 represents a typical domestically developed innovative anti‑influenza drug, providing a new option for clinical influenza treatment.In 2025, global GP681 production reached approximately 1.2 million bottles
GP681 (Suraxavir) is China’s first domestically developed innovative anti-influenza drug targeting the PA protein. With its differentiated advantages of single-dose administration, rapid onset of action and low drug resistance rate, it has entered the domestic anti-influenza drug market worth tens of billions of yuan, breaking the monopoly of foreign products targeting the same site.
Its clinical data are all derived from Chinese populations, providing evidence more suitable for local patients. It demonstrates comparable efficacy and safety to international counterparts, with a significantly lower rate of drug resistance mutations, highlighting its prominent clinical value.
Currently dominated by oseltamivir and baloxavir, the market sees GP681 poised to rapidly penetrate hospital and retail channels and capture share in the PA inhibitor segment, backed by its status as a domestic innovative drug, pricing advantages and expected inclusion in medical insurance.
Meanwhile, the developer is expanding indications for children and high-risk populations and promoting overseas layout, further unlocking market potential and establishing GP681 as a representative breakthrough for domestic innovative drugs in the respiratory field.
This report is a detailed and comprehensive analysis for global GP681 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global GP681 market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global GP681 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global GP681 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global GP681 market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GP681
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GP681 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qingfeng Pharmaceutical, Jiangxi Kerui Pharmaceutical, Yinxingshu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
GP681 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20mg / ablet
40mg / ablet
Market segment by Target Population
Adolescents Aged 12 Years And Above
Adults
Market segment by Combination Medication
Combined With Antipyretic And Analgesic Drugs
Combined With Mucolytic And Antitussive Drugs
Market segment by Sales Channels
Hospitals
Retail
Online
Market segment by Application
Treatment of Influenza A
Treatment of Influenza B
Others
Major players covered
Qingfeng Pharmaceutical
Jiangxi Kerui Pharmaceutical
Yinxingshu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GP681 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GP681, with price, sales quantity, revenue, and global market share of GP681 from 2021 to 2026.
Chapter 3, the GP681 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GP681 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and GP681 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GP681.
Chapter 14 and 15, to describe GP681 sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global GP681 Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 20mg / ablet
- 1.3.3 40mg / ablet
- 1.4 Market Analysis by Target Population
- 1.4.1 Overview: Global GP681 Consumption Value by Target Population: 2021 Versus 2025 Versus 2032
- 1.4.2 Adolescents Aged 12 Years And Above
- 1.4.3 Adults
- 1.5 Market Analysis by Combination Medication
- 1.5.1 Overview: Global GP681 Consumption Value by Combination Medication: 2021 Versus 2025 Versus 2032
- 1.5.2 Combined With Antipyretic And Analgesic Drugs
- 1.5.3 Combined With Mucolytic And Antitussive Drugs
- 1.6 Market Analysis by Sales Channels
- 1.6.1 Overview: Global GP681 Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospitals
- 1.6.3 Retail
- 1.6.4 Online
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global GP681 Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Treatment of Influenza A
- 1.7.3 Treatment of Influenza B
- 1.7.4 Others
- 1.8 Global GP681 Market Size & Forecast
- 1.8.1 Global GP681 Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global GP681 Sales Quantity (2021-2032)
- 1.8.3 Global GP681 Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Qingfeng Pharmaceutical
- 2.1.1 Qingfeng Pharmaceutical Details
- 2.1.2 Qingfeng Pharmaceutical Major Business
- 2.1.3 Qingfeng Pharmaceutical GP681 Product and Services
- 2.1.4 Qingfeng Pharmaceutical GP681 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Qingfeng Pharmaceutical Recent Developments/Updates
- 2.2 Jiangxi Kerui Pharmaceutical
- 2.2.1 Jiangxi Kerui Pharmaceutical Details
- 2.2.2 Jiangxi Kerui Pharmaceutical Major Business
- 2.2.3 Jiangxi Kerui Pharmaceutical GP681 Product and Services
- 2.2.4 Jiangxi Kerui Pharmaceutical GP681 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Jiangxi Kerui Pharmaceutical Recent Developments/Updates
- 2.3 Yinxingshu Pharmaceutical
- 2.3.1 Yinxingshu Pharmaceutical Details
- 2.3.2 Yinxingshu Pharmaceutical Major Business
- 2.3.3 Yinxingshu Pharmaceutical GP681 Product and Services
- 2.3.4 Yinxingshu Pharmaceutical GP681 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Yinxingshu Pharmaceutical Recent Developments/Updates
3 Competitive Environment: GP681 by Manufacturer
- 3.1 Global GP681 Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global GP681 Revenue by Manufacturer (2021-2026)
- 3.3 Global GP681 Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of GP681 by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 GP681 Manufacturer Market Share in 2025
- 3.4.3 Top 6 GP681 Manufacturer Market Share in 2025
- 3.5 GP681 Market: Overall Company Footprint Analysis
- 3.5.1 GP681 Market: Region Footprint
- 3.5.2 GP681 Market: Company Product Type Footprint
- 3.5.3 GP681 Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global GP681 Market Size by Region
- 4.1.1 Global GP681 Sales Quantity by Region (2021-2032)
- 4.1.2 Global GP681 Consumption Value by Region (2021-2032)
- 4.1.3 Global GP681 Average Price by Region (2021-2032)
- 4.2 North America GP681 Consumption Value (2021-2032)
- 4.3 Europe GP681 Consumption Value (2021-2032)
- 4.4 Asia-Pacific GP681 Consumption Value (2021-2032)
- 4.5 South America GP681 Consumption Value (2021-2032)
- 4.6 Middle East & Africa GP681 Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global GP681 Sales Quantity by Type (2021-2032)
- 5.2 Global GP681 Consumption Value by Type (2021-2032)
- 5.3 Global GP681 Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global GP681 Sales Quantity by Application (2021-2032)
- 6.2 Global GP681 Consumption Value by Application (2021-2032)
- 6.3 Global GP681 Average Price by Application (2021-2032)
7 North America
- 7.1 North America GP681 Sales Quantity by Type (2021-2032)
- 7.2 North America GP681 Sales Quantity by Application (2021-2032)
- 7.3 North America GP681 Market Size by Country
- 7.3.1 North America GP681 Sales Quantity by Country (2021-2032)
- 7.3.2 North America GP681 Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe GP681 Sales Quantity by Type (2021-2032)
- 8.2 Europe GP681 Sales Quantity by Application (2021-2032)
- 8.3 Europe GP681 Market Size by Country
- 8.3.1 Europe GP681 Sales Quantity by Country (2021-2032)
- 8.3.2 Europe GP681 Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific GP681 Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific GP681 Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific GP681 Market Size by Region
- 9.3.1 Asia-Pacific GP681 Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific GP681 Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America GP681 Sales Quantity by Type (2021-2032)
- 10.2 South America GP681 Sales Quantity by Application (2021-2032)
- 10.3 South America GP681 Market Size by Country
- 10.3.1 South America GP681 Sales Quantity by Country (2021-2032)
- 10.3.2 South America GP681 Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa GP681 Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa GP681 Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa GP681 Market Size by Country
- 11.3.1 Middle East & Africa GP681 Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa GP681 Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 GP681 Market Drivers
- 12.2 GP681 Market Restraints
- 12.3 GP681 Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of GP681 and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of GP681
- 13.3 GP681 Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 GP681 Typical Distributors
- 14.3 GP681 Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on GP681. Industry analysis & Market Report on GP681 is a syndicated market report, published as Global GP681 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of GP681 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
